Bacterial Conjunctivitis Diagnosed
Placeholder: red eye with sticky purulent discharge signals bacterial cause.
- S. aureus, H. influenzae: Typical pathogens (placeholder text)
- ~10–14 days: Untreated duration (placeholder text)
- Purulent, sticky: Discharge type (placeholder text)
- While discharging: Contagious period (placeholder text)
Recognizing bacterial conjunctivitis
Placeholder: purulent discharge, crusting, and unilateral onset differ from viral or allergic causes.
Why bacterial load matters
Placeholder: bacterial density on the conjunctiva drives inflammation and discharge volume.
Antibiotic Eye Drops Started
Placeholder: topical antibiotic drops begin at a chosen dosing frequency.
- Fluoroquinolones: Common agents (placeholder text)
- 4–6×/day: Typical frequency (placeholder text)
- 5–7 days: Course length (placeholder text)
- 1–2 days: Onset of effect (placeholder text)
Dosing frequency matters
Placeholder: more frequent dosing keeps drug levels above the killing threshold.
Administering drops correctly
Placeholder: proper technique avoids contamination and improves drug contact time.
Bacterial Load Declines Over the Course
Placeholder: repeated dosing steadily reduces bacterial density on the eye surface.
- Dose frequency: Decline driver (placeholder text)
- Faster at high freq: Load half-life (placeholder text)
- Rises if under-dosed: Resistance risk (placeholder text)
- ~Day 3–4: Peak effect day (placeholder text)
Exponential-style clearance
Placeholder: each dose knocks load down further, compounding across the day.
Why missed doses slow clearance
Placeholder: gaps let bacteria rebound between applications.
Discharge and Redness Fade
Placeholder: symptoms trail bacterial load with a short lag as tissue heals.
- Steadily decreasing: Discharge trend (placeholder text)
- Fading by day 5–6: Redness trend (placeholder text)
- ~1 day behind load: Symptom lag (placeholder text)
- Noticeably by day 4: Comfort improves (placeholder text)
Symptoms lag bacterial clearance
Placeholder: inflammation takes time to resolve after bacteria are suppressed.
Why finishing the course matters
Placeholder: stopping early at symptom relief leaves residual bacteria behind.
Full Course vs Early Discontinuation
Placeholder: completing all 7 days prevents recurrence; stopping early risks rebound.
- Near-complete clearance: Full course outcome (placeholder text)
- Recurrence, resistance: Early stop risk (placeholder text)
- 7 days: Recommended course (placeholder text)
- Days after stopping: Recurrence window (placeholder text)
Completing the course
Placeholder: full-length dosing clears residual bacteria and prevents rebound.
Risk of stopping early
Placeholder: surviving bacteria can multiply again and select for resistance.